Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2016-01-06

Clinical Trial Update: A Study Comparing LBEC0101 to Enbrel® in Subjects With Active Rheumatoid Arthritis Despite Methotrexate Therapy [Phase 3]

View source ↗

Summary

A Phase 3 study comparing the biosimilar LBEC0101 to Enbrel (etanercept) in adults with active rheumatoid arthritis despite methotrexate therapy; the current st…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ENBREL (etanercept)
  • LBEC0101 (etanercept)

Snippet

Sponsor: LG Life Sciences | Conditions: Arthritis, Rheumatoid | Phase 3 | Status: UNKNOWN